IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 1.55 (2012 - 2016).    Offical Sponser for International Conference in malaysia ,  https://www.icmhas.com/

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
Budget Impact Analysis on the intranasal form of Interferon-Gamma in the Complex Therapy of Influenza in the Russian Federation

Author: S.L. PLAVINSKIY, P.I. SHABALKIN, J.A. ISAKOVA
Abstract: To estimate the budget impact on the intranasal form of interferon-gamma for the health care system of the Russian Federation, data was used from the research work by Sologub T.V. et al. on the evaluation of clinical and economic efficiency and the profitability of using recombinant interferon-gamma (Ingaron) in complex therapy of influenza patients. The conducted calculations using the cost-effectiveness indicator for recombinant interferon-gamma showed a positive budget impact for the health care system: in the form of a total budget savings of 1331568 thousand rubles with the subsequent reduction of the estimated indicator of the economic burden of influenza on 43% that will be reflected in the budget savings of 1018909 thousand rubles with current incidence.
Keyword: influenza, interferon-gamma, budget impact analysis, acute infections of the upper respiratory tract
DOI: https://doi.org/10.31838/ijpr/2018.10.04.053
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events
SCImago Journal & Country Rank
hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477